COPENHAGEN, Denmark, September 4, 2026 – Bavarian Nordic A/S (OMX: BAVA) has received information about the following transactions of the company’s shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such.
| 1. | Details of the person discharging managerial responsibilities/person closely associated  | ||
| a) | Name | Russell Thirsk | |
| 2. | Reason for the notification | ||
| a) | Position/status | Executive Vice President and Chief Operating Officer of Bavarian Nordic A/S | |
| b) | Initial notification/Amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Bavarian Nordic A/S | |
| b) | LEI | 2138006JCDVYIN6INP51 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument
Identification code |
Shares
DK0015998017 |
|
| b) | Nature of the transaction | Subscription of new shares through exercise of warrants | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| Â | Â | DKK 190.11 | 28,590 |
| d) | Aggregated information
|
Â
28,590 |
|
| e) | Date of the transaction | 2026-09-04 | |
| f) | Place of the transaction | Nasdaq Copenhagen A/S, XCSE | |
| a) | Description of the financial instrument, type of instrument
Identification code |
Shares
DK0015998017 |
|
| b) | Nature of the transaction | Sale | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| Â | Â | DKK 215.4782 | 28,590 |
| d) | Aggregated information
|
Â
28,590 |
|
| e) | Date of the transaction | 2026-09-04 | |
| f) | Place of the transaction | Nasdaq Copenhagen A/S, XCSE | |
| 1. | Details of the person discharging managerial responsibilities/person closely associated  | ||
| a) | Name | Anja Gjøl | |
| 2. | Reason for the notification | ||
| a) | Position/status | Member of the Board of Directors of Bavarian Nordic A/S | |
| b) | Initial notification/Amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Bavarian Nordic A/S | |
| b) | LEI | 2138006JCDVYIN6INP51 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument
Identification code |
Shares
DK0015998017 |
|
| b) | Nature of the transaction | Sale | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| Â | Â | DKK 222.00 DKK 221.80 |
281 64 |
| d) | Aggregated information
|
Â
345 |
|
| e) | Date of the transaction | 2026-09-03 | |
| f) | Place of the transaction | Nasdaq Copenhagen A/S, XCSE | |
About Bavarian Nordic
Bavarian Nordic is a global vaccine company with a mission to improve health and save lives through innovative vaccines. We are a preferred supplier of mpox and smallpox vaccines to governments to enhance public health preparedness and have a leading portfolio of travel vaccines. For more information, visit www.bavarian-nordic.com
Contact investors:
Anders Hjort, Head of Investor Relations, [email protected], Tel: +45 44 74 99 58
Graham Morrell, Gilmartin Group, [email protected], Tel: +1 781 686 9600
Contact media:
Isabel Hagbrink, Head of Media Relations, [email protected], Tel: +45 71 79 67 33
Company Announcement no. 40 / 2026
Attachment
- Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
